Cite
MLA Citation
M. Sibartie et al.. “Evolocumab use and LDL-C lowering in a cohort of european patients with familial hypercholesterolemia (FH) - Results from the Heymans study.” Atherosclerosis, vol. 331, 2021, pp. e253–. http://access.bl.uk/ark:/81055/vdc_100156435011.0x000062